Anti-CCL11 Recombinant Antibody (Bertilimumab) (CAT#: TAB-724)

Recombinant human monoclonal antibody expressed in CHO binding to human CCL11. Bertilimumab is a human monoclonal antibody that binds to eotaxin-1, an important regulator of overall eosinophil function. It was to be used to treat severe allergic disorders.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG4 - kappa
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in ELISA, Neut, IF, IP, FC, FuncS and most other immunological methods.
  • Trade name
  • cat-213
  • CAS
  • 375348-49-5
  • Generic Name
  • bertilimumab
  • Related Disease
  • Allergies, severe ocular

Product Property

  • Purity
  • >95.0%, determined by analysis by RP-HPLC & analysis by SDS-PAGE.
  • Storage
  • Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.

Target

  • Alternative Names
  • bertilimumab;cat-213;375348-49-5;CAT-213;CAT213;iCo-008;CAT-212;CCL11;chemokine (C-C motif) ligand 11;SCYA11, small inducible cytokine subfamily A (Cys Cys), member 11 (eotaxin);eotaxin;eotaxin 1;MGC22554;eotaxin-1;C-C motif chemokine 11;small-inducible c

Related Resources

  • Biosimilar Overview
Please refer to Bertilimumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Bertilimumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Bertilimumab"

Afuco™ Anti-CCL11 ADCC Recombinant Antibody (Bertilimumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human CCL11. Bertilimumab is a human monoclonal antibody that binds to eotaxin-1, an important regulator of overall eosinophil function. It was to be used to treat severe allergic disorders.

See other products for "CCL11"

Fab Fragment Antibody

CAT Product Name Application Type
DrMAB-1054 Recombinant Mouse Anti-Human CCL11 Antibody Fab Fragment ELISA Fab

Recombinant Antibody

CAT Product Name Application Type
MOB-1389MZ Mouse Anti-CCL11 Recombinant Antibody (clone nythil-FPU2) ELISA Mouse IgG1

Blocking Antibody

CAT Product Name Application Type
NEUT-109CQ Rat Anti-CCL11 Recombinant Antibody (clone L403H11) Block, ELISA Rat IgG1, κ

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-0501 Hi-Affi™ Rabbit Anti-CCL11 Recombinant Antibody (clone DS501AB) WB Rabbit IgG

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-724 Afuco™ Anti-CCL11 ADCC Recombinant Antibody (Bertilimumab), ADCC Enhanced FC, IP, ELISA, Neut, FuncS ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-724. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare